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Abstract
Objective: S100B is produced by glia of the central and
peripheral nervous systems and is considered a marker
of neurologic injury in the perinatal period. Indeed,
increased neonatal urine S100B concentration is asso-
ciated with adverse neurological outcomes including
intraventricular hemorrhage and hypoxic-ischemic
encephalopathy, while elevated adult serum concentra-
tions are associated with infectious diseases/sepsis. The
objective of this study was to determine whether amni-
otic fluid (AF) S100B concentrations change with advanc-
ing gestational age and intra-amniotic infection (IAI).
Study design: S100B concentration was measured in
the AF of women in midtrimester, at term, and in preg-
nancies with preterm labor and intact membranes (PTL)
or preterm premature rupture of membranes (PPROM),
with and without IAI. Placental pathology was performed
and neonatal outcomes were analyzed.
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Results: (1) AF S100B concentration did not change dur-
ing gestation; (2) patients with IAI had significantly higher
AF S100B concentration than those without IAI following
an episode of PTL or PPROM and; (3) neonates who had
morbidity/mortality had had an elevated AF S100B con-
centration; however, this could be explained by the asso-
ciation with intra-amniotic infection/inflammation. Thus,
AF S100B concentration was not an independent predic-
tor of neonatal morbidity or fetal/neonatal death.
Conclusions: An elevated concentration of AF S100B
may reflect intra-amniotic infection/inflammation and not
necessarily fetal neurologic damage.
Keywords: Chorioamnionitis; fetal inflammation; funisitis;
interleukin-6; intra-amniotic infection; neonatal morbidity;
parturition; preterm premature rupture of membranes.
Introduction
S100 proteins are dimeric, acidic proteins that constitute
the largest subfamily of EF-hand proteins w29x. S100B
has a very short half-life (25 min) and is eliminated in the
urine w20x. Due to its high concentration in astrocytes and
oligodendrocytes of the nervous system w31, 40x, S100B
has been proposed to be a marker of cerebral damage
in the perinatal period. Evidence in support of this view
includes: (1) elevated concentrations of urinary, cord
blood, and serum S100B in neonates are associated with
neonatal hypoxic-ischemic encephalopathy (HIE) and
have been proposed to be an early biochemical indicator
of HIE w13, 24, 32x. Indeed, high urine S100B concentra-
tions within three days of birth w12x were found to be
predictive of adverse neurologic outcome in asphyxiated
full-term infants at 12 months of age; (2) elevated urine
and blood S100B concentrations were also demonstrat-
ed in term or preterm neonates who subsequently devel-
oped intra-ventricular hemorrhage (IVH) w7, 12, 14x.
Moreover, urine S100B concentration at birth significantly
correlated with the degree of IVH (r2s0.76, P-0.001) w7x;
and (3) an elevated urinary concentration of S100B in
neonates with intrauterine growth restriction was asso-
ciated with adverse short-term neurologic outcome (7
day) w4x.
Neonatal death has also been associated with high
urine and AF concentrations of S100B. Indeed, the
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S100B first urine concentration of preterm newborns had
a sensitivity of 100% and a specificity of 97.8% for pre-
dicting neonatal death, using a cut-off of 12.93 MOM w9x.
Furthermore, amniotic fluid S100B concentration was
found to be significantly higher in women undergoing
midgestation genetic amniocentesis who later had spon-
taneous fetal death before 28 weeks of gestational age
w5x. Since S100B is eliminated in the urine w20x, it is pos-
sible that fetal urine contributes to the elevated S100B
concentration in the AF in these pregnancies.
Elevated S100B cerebral spinal fluid (CSF), serum, and
plasma concentrations are also associated with infection
and inflammation w3, 6, 10, 23, 35x. Neonates with bac-
terial meningitis have significantly higher median CSF
concentrations of S100B than those with septicemia
without meningitis. Moreover, the severity of CNS infec-
tion is associated with a high CSF S100B concentration
as demonstrated by the observation that neonates with
bacterial meningitis and encephalitis had the highest
median CSF S100B concentration w10x. Extra-cerebral
infectious diseases and inflammation are also associated
with high serum S100B concentrations. For example,
73% of patients with bacterial meningitis, as well as 25%
of patients with bacterial pneumonia or enteritis had ele-
vated serum S100B concentrations w35x. Patients with
septic shock also have serum concentrations of S100B
equivalent to those described in patients with severe
traumatic brain injury w23x. Finally, plasma S100B con-
centrations in preterm fetal sheep were significantly high-
er following systemic endotoxin administration, but not
saline administration w6x.
The objective of this study was to determine whether
amniotic fluid concentrations of S100B change with
advancing gestational age in normal pregnancy and with
intra-amniotic infection in patients with preterm labor and




A cross-sectional study was conducted using our clinical data-
base and bank of biological samples. This study included 343
women with singleton pregnancies and no congenital anomalies
or karyotype abnormalities in the following groups: (1) mid-
trimester (ns74); (2) term not in labor (ns27); (3) term in labor
(ns51); (4) preterm labor (PTL) who delivered at term (ns35);
(5) preterm labor without intra-amniotic infection (IAI) who deliv-
ered preterm (ns49); (6) preterm labor with IAI (ns25); (7) pre-
term premature rupture of membranes (preterm PROM) without
IAI (ns41); and (8) preterm PROM with IAI (ns41). Intra-amniotic
infection was defined as a positive amniotic fluid culture for
microorganisms. Normal pregnant women at term, with or with-
out labor, had a gestational age of G37 weeks and -42 weeks.
Preterm labor was characterized by the presence of regular uter-
ine contractions occurring at a frequency of at least two every
10 min, with cervical changes at -37 completed weeks of ges-
tation that required hospitalization. Rupture of membranes was
diagnosed by testing for pooling, nitrazine paper color change,
and ferning.
Amniotic fluid was collected by trans-abdominal amniocen-
tesis under ultrasonographic guidance. Fluid not required for
clinical purposes was centrifuged to remove cellular and partic-
ulate matter. Aliquots of amniotic fluid were stored at y708C
until analysis. A sample of amniotic fluid was transported to the
laboratory to be cultured for aerobic and anaerobic species. All
samples except those from the midtrimester were also cultured
for genital mycoplasmas (Ureaplasma urealyticum and Myco-
plasma hominis). Amniotic fluid white blood cell (WBC) count,
Gram stain, and glucose concentrations were used in the man-
agement of patients with preterm labor with intact membranes
and preterm PROM. Pregnant patients were enrolled between
October 1990 and June 2002 at Hutzel Hospital, Detroit, Mich-
igan, Pennsylvania Hospital, Philadelphia, Pennsylvania, and
Sotero del Rio Hospital, Puente Alto, Chile. The collection of
samples for research was approved by the Institutional Review
Boards of Wayne State University, Pennsylvania Hospital, and
Sotero del Rio Hospital, as well as the National Institute of Child
Health and Human Development, National Institutes of Health,
Department of Health and Human Services.
Many of these samples have been previously employed to
study the biology of inflammation, hemostasis, angiogenesis
regulation, and growth factor concentrations.
S100B and IL-6 immunoassays
Amniotic fluid S100B and IL-6 concentrations were measured
with commercially available enzyme-linked immunosorbent
assays. Immunoassay kits for S100B were obtained from
BioVendor, LLC (Chandler, NC, USA) and IL-6 assays were pur-
chased from R&D Systems (Minneapolis, MN, USA). Both S100B
and IL-6 assays were specifically validated for use with human
amniotic fluid in our laboratory prior to the conduction of this
study. Validation included spike and recovery experiments,
which produced parallel curves indicating that amniotic fluid
constituents did not interfere with antigen-antibody binding in
these assay systems. The concentrations of S100B or IL-6 in
amniotic fluid samples were determined by interpolation from
individual standard curves composed of human S100B or IL-6.
The calculated inter-assay coefficients of variation (CV) for
S100B and IL-6 immunoassays in our laboratory were 6.32%
and 9.02%, respectively; while, calculated intra-assay CVs for
S100B and IL-6 were 2.65% and 7.24%, respectively. The
detection limits (sensitivities) were calculated to be 23.30 pg/mL
for S100B and 2.28 pg/mL for IL-6 assays.
Diagnosis of neonatal morbidity, funisitis and
chorioamnionitis
Respiratory distress syndrome (RDS), bronchopulmonary dys-
plasia (BPD), necrotizing enterocolitis (NEC), neonatal sepsis,
and IVH were diagnosed according to the definitions previously
described in detail w38, 39x. Placental pathology was available
for 58 of the 74 patients who delivered preterm with intact mem-
branes and 77 of the 82 patients with preterm PROM. Funisitis
was diagnosed as the presence of neutrophil infiltration into the
umbilical vessel walls or Wharton’s jelly, and histologic cho-
rioamnionitis was defined as the presence of acute inflammatory
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changes on examination of a membrane roll and chorionic plate
of the placenta with the use of previously published criteria w38,
39x.
Statistical analysis
The Shapiro-Wilk test was used to evaluate the distribution of
data. Amniotic fluid S100B and IL-6 concentrations were not
normally distributed. Therefore, the Mann-Whitney U-test was
used for comparison of continuous variables and the Kruskal-
Wallis test with post hoc analysis was employed for multiple
comparisons. Spearman’s rho was utilized for nonparametric
correlations. Receiver operating characteristic (ROC) curve anal-
ysis was performed to determine the diagnostic value of S100B
AF concentration for determination of IAI. Logistic regression
was used to determine if the AF concentration of S100B was an
independent explanatory variable for a composite of neonatal
morbidity (including RDS, BPD, NEC, IVH, and sepsis), IVH
alone, and fetal/neonatal death after controlling for gestational
age at delivery. The statistical package employed was SPSS 12
(SPSS Inc, Chicago, IL, USA). A P-value of -0.05 was consid-
ered statistically significant.
Results
Table 1 displays the demographic and clinical character-
istics of the study groups. The amniotic fluid S100B con-
centration (median and range) by study group is
displayed in Table 2. Of note, the AF concentration of
S100B did not significantly change with advancing ges-
tational age w(median and range: midtrimester 23.4
pg/mL (23.3–182.8) vs. term 23.7 pg/mL (23.3–370.9);
Ps0.76)x. There was no significant difference in AF con-
centration of S100B between patients with labor at term
and no labor wmedian and range: 27.0 pg/mL
(23.3–370.9) vs. 23.3 pg/mL (23.3–140.5); Ps0.20x.
Among patients with preterm labor and intact mem-
branes, those with IAI had significantly higher S100B AF
concentration wmedian and range: 1133.6 pg/mL
(23.3–29,221.2)x than those who delivered preterm with-
out IAI wmedian and range: 99.0 pg/mL (23.3–4731.9);
P-0.05x and those who delivered at term wmedian and
range: 51.0 pg/mL (23.3–130.0); P-0.05x (Figure 1A).
Similarly, the AF S100B concentration was significantly
higher in patients with preterm PROM and IAI than in
those without IAI wmedian and range: 98.3 pg/mL (23.3–
19,922.5) vs. 49.0 pg/mL (23.3–17,683.7); Ps0.018x
(Figure 1B). ROC curve analysis revealed that the sensi-
tivity and specificity of S100B AF concentration for pre-
dicting IAI following an episode of preterm labor with
intact membranes using a cutoff point of 308.23 pg/mL
were 72% and 90.5%, respectively.
The amniotic fluid S100B concentration correlated sig-
nificantly with amniotic fluid IL-6 concentration in
patients with preterm delivery following preterm labor
with intact membranes (rs0.74; P-0.001), as well as in
388 Friel et al., S100B and intra-amniotic infection/inflammation























































































































































































































































Figure 1 Amniotic fluid concentration of S100B according to
pregnancy outcome and AF culture results. (A) Among patients
who delivered preterm, those with intra-amniotic infection had
significantly higher S100B AF concentration wmedian: 1133.6
pg/mL (23.3–29,221.2)x than those who delivered preterm with-
out IAI wmedian: 99.0 pg/mL (23.3–4731.9); P-0.05x or those
who delivered at term wmedian: 51.0 pg/mL (23.3–130.0);
P-0.05x. (B) Similarly, the AF S100B concentration was signifi-
cantly higher in patients with preterm PROM and IAI than in
those without IAI wmedian and range: 98.3 pg/mL
(23.3–19,922.5) vs. 49.0 pg/mL (23.3–17,683.7); Ps0.018x.
patients with preterm PROM (rs0.52; P-0.001). Patients
without IAI, but with intra-amniotic inflammation, defined
as amniotic fluid IL-6 concentration of )2.6 ng/mL w37x,
had a significantly higher S100B concentration than
those without inflammation, regardless of membrane
status (Table 3). Moreover, patients with histological cho-
rioamnionitis also had a significantly higher median
S100B AF concentration than those without chorioam-
nionitis, regardless of membrane status (Table 3). Finally,
patients with preterm labor and intact membranes with
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Table 3 Amniotic fluid S100B concentration with or without inflammation in patients with preterm labor and intact membranes or
preterm PROM.
No Yes P-value
Preterm labor and intact membranes
Intra-amniotic inflammation 68.3 (23.3–284.2) 190.3 (43.9–4737.9) -0.001
(AF IL-6)2.6 ng/mL) ns27 ns22
Histologic chorioamnionitis 79.2 (23.3–7,125.3) 788.4 (27.9–29,221.2) -0.001
ns23 ns35
Funisitis 115.8 (23.3–13,842.2) 865.9 (33.1–29,221.2) 0.003
ns37 ns21
Preterm premature rupture of membranes
Intra-amniotic inflammation 45.9 (23.3–318.5) 151.4 (25.2–17,683.7) 0.018
(AF IL-6)2.6 ng/mL) ns32 ns9
Histologic chorioamnionitis 45.9 (23.3–10,164.3) 82.8 (23.3–19,922.5) 0.018
ns32 ns45
Funisitis 58.9 (23.3–10,164.3) 82.8 (23.3–19,922.5) 0.15
ns44 ns33
*AF S100B pg/mL (median and range).
Table 4 Amniotic fluid S100B concentration with or without adverse neonatal outcomes.
No Yes P-value
Respiratory distress syndrome 70.4 (23.3–191.4) 157.5 (23.3–29,221.2) 0.001
ns16 ns33
Bronchopulmonary dysplasia 83.9 (23.3–13,842.2) 864.8 (122.1–29,221.2) 0.001
ns38 ns8
Necrotizing enterocolitis 88.6 (23.3–13,842.2) 4399.3 (197.5–29,221.2) 0.003
ns43 ns4
Proven sepsis 109.0 (23.3–13,842.2) 1476.5 (253.1–29,221.2) 0.03
ns38 ns3
Death 118.9 (23.3–29,221.2) 1100.6 (43.9–5,858.8) 0.002
ns58 ns16
*AF S100B pg/mL (median and range).
funisitis, the histopathologic hallmark of the fetal inflam-
matory response syndrome w27x, had a significantly high-
er median S100B AF concentration than those without
funisitis. In contrast, there was no significant difference
in the median AF S100B concentration between patients
with preterm PROM with or without funisitis (Table 3).
Short-term neonatal outcomes were analyzed for
patients with preterm labor and intact membranes. Amni-
otic fluid S100B concentrations were significantly higher
in pregnancies with neonates who subsequently had
complications of respiratory distress syndrome, broncho-
pulmonary dysplasia, necrotizing enterocolitis, and prov-
en sepsis (Table 4). Furthermore, among the cohort which
underwent neurosonography, S100B concentration was
significantly higher in pregnancies with neonates that
developed intraventricular hemorrhage than those that
did not wmedian and range: 1305.1 pg/mL (122.1–
29,221.2) vs. median and range: 113.7 pg/mL
(23.3–13,842.2); Ps0.005x (Figure 2A). S100B concen-
tration did not significantly correlate with intraventricular
hemorrhage grade in this small subset of patients
(rs0.33; Ps0.35; ns10). After excluding these 10
patients from the analysis, however, S100B AF concen-
tration remained significantly higher in patients with PTL
with IAI than those who delivered preterm without IAI
wmedian and range: 865.9 pg/mL (23.3–13,842.2) vs.
91.3 pg/mL (23.3–4731.9); Ps0.002x, suggesting that
the primary association is with intra-amniotic infection
and inflammation (Figure 2B). The relationship between
gestational age and S100B with a composite of neonatal
morbidity, including RDS, BPD, NEC, IVH, and sepsis
was investigated using logistic regression analysis of all
patients following an episode of preterm labor with intact
membranes. Gestational age at birth was a significant
predictor of composite neonatal morbidity (OR 0.71, 95%
CI 0.61–0.81, P-0.001), while S100B was not an inde-
pendent predictor (Ps0.39). Logistic regression analysis
was also used to investigate the relationship between
gestational age at birth, mode of delivery, and S100B
with IVH. Gestational age at delivery was the only explan-
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Figure 2 Amniotic fluid concentration of S100B in patients in
preterm labor with intact membranes who subsequently deliv-
ered preterm neonates who underwent neurosonography. There
was a significant difference in the AF S100B concentration
between patients with PTL with and without IVH wmedian:
1305.1 pg/mL (122.1–29,221.2) vs. median: 113.7 pg/mL
(23.3–13,842.2); Ps0.005x. After excluding these 10 patients
from the analysis, however, S100B AF concentration remained
significantly higher in patients with PTL with IAI than those who
delivered preterm without IAI wmedian and range: 865.9 pg/mL
(23.3–13,842.2) vs. 91.3 pg/mL (23.3–4731.9); Ps0.002x.
atory variable for the occurrence of IVH (OR 0.77, 95%
CI 0.60–0.99, Ps0.04), while mode of delivery (Ps0.97)
and the AF S100B concentration (Ps0.075) were not.
Finally, S100B concentration was significantly higher in
patients with preterm labor and intact membranes with
subsequent intrapartum or neonatal death than those
alive at discharge (Table 4). A multivariate logistic regres-
sion analysis revealed that these deaths were related to
gestational age at delivery (OR 0.35, 95% CI 0.19–0.62,
P-0.001). AF S100B concentration was not an inde-
pendent predictor of fetal or neonatal death (Ps0.81).
Discussion
Principal findings of the study
Preterm parturition following preterm labor with intact
membranes and intra-amniotic infection/inflammation is
associated with a significantly higher median AF concen-
tration of S100B, even after excluding patients whose
neonates subsequently had overt adverse neurologic
outcome, i.e., intra-ventricular hemorrhage. This obser-
vation suggests that an elevation in the AF concentration
of S100B may reflect infection/inflammation and not nec-
essarily fetal neurologic damage. Furthermore, the AF
concentration of S100B is not an independent predictor
of composite neonatal morbidity (including RDS, BPD,
IVH, NEC, and neonatal sepsis), IVH alone, or fetal/neo-
natal death.
Amniotic fluid concentration of S100B does not
change with advancing gestational age
Our results that AF S100B concentration did not change
with gestational age are novel. Prior reports indicated
that the correlation of S100B concentration decreased
with gestational age in the cord blood, urine, and saliva
of neonates w8, 11, 15x. However, this may reflect that
these biological samples were obtained from patients
with complications of pregnancy leading to preterm
delivery. Such samples cannot be obtained in preterm
gestations without complications.
Intra-amniotic infection is associated with a high
amniotic fluid S100B concentration
The findings that preterm patients with IAI had a signifi-
cantly higher S100B AF concentration than those without
IAI, regardless of membrane status, are also novel, and
indicate that an elevation in AF concentration of S100B
may reflect infection/inflammation. A growing body of
evidence indicates that a high serum or plasma concen-
tration of S100B is associated with systemic infection/
inflammation including: (1) serum concentrations of
S100B are elevated in bacterial sepsis, as well as cere-
bral infection w23x; (2) patients with an initial serum S100B
concentration )0.50 ng/mL also had elevated serum
interleukin-8 and polymorphonuclear elastase plasma
concentrations w23x; (3) patients with severe sepsis and
septic shock had an elevated serum S100B concentra-
tion, particularly those who died early (within 4 days of
intensive care unit admission) w25x; (4) S100B concentra-
tion was the strongest independent predictor of intensive
care unit survival w25x; and (5) systemic endotoxin admin-
istration to preterm fetal sheep resulted in significantly
higher S100B plasma concentrations post-administration
compared with saline treatment w6x.
Although ROC curve analysis revealed a high sensitiv-
ity and specificity of S100B AF concentration for pre-
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dicting IAI, amniotic fluid interleukin-6 or MMP-8
concentration determinations remain the most sensitive
tests for IAI w16, 22x. Furthermore, S100B is not better
than a rapid matrix metalloproteinase-8 bedside test
(sensitivity 83% and specificity 95%) w26x.
High amniotic fluid S100B associated with adverse
neonatal outcomes is related to gestational age
A significantly higher AF concentration of S100B is asso-
ciated with adverse neonatal outcomes, including acute
and chronic lung disease, necrotizing enterocolitis, neo-
natal sepsis, as well as IVH and death. The AF concen-
tration of S100B, however, was not an independent
predictor of composite neonatal morbidity (including
RDS, BPD, IVH, NEC, and neonatal sepsis), IVH, or fetal/
neonatal death, but may reflect infection/inflammation
which leads to earlier preterm delivery.
What are the possible sources of S100B in the
amniotic fluid?
S100B protein is found in the placenta, as determined by
immunohistochemistry w21, 36x and by Western blot anal-
ysis w21x. However, the specificity of the polyclonal anti-
bodies used in these studies remains unclear. It is
possible that S100P, a placental protein having approxi-
mately 50% sequence homology with S100B, may have
cross-reacted with the polyclonal antibodies w2x. More
compelling evidence that fetal membranes produce
S100B was reported in patients with preeclampsia w34x.
S100B mRNA expression in the amnion of these patients
was measured by RT-PCR using sequence-specific prim-
ers for S100B. Amnion S100B mRNA expression was
significantly higher than that of amnion from uncompli-
cated term pregnancies (P-0.05). Furthermore, the AF
S100B protein concentration in patients with pre-
eclampsia, as measured by ELISA, was significantly
higher than that of uncomplicated term pregnancies
(P-0.05). This study demonstrates that the amnion
could be a source of S100B contributing to the AF con-
centration, which must be taken into consideration.
The conventional view is that the main source of
S100B is neuronal tissue. However, S100B is also found
in adipocytes, melanocytes, and chondrocytes, albeit in
lower concentrations w18, 19x. Indeed, high serum S100B
concentrations have been reported in trauma patients
without head injuries, particularly those with large frac-
tures or abdominal injury w1, 30x. Another study demon-
strated increased concentrations of serum S100B in a
cohort of critically ill patients without brain injury w28x.
These patients had various diagnoses, such as acute
respiratory distress syndrome, trauma, acute pancreati-
tis, as well as hemorrhagic-, cardiogenic- and septic
shock. Thus, it is possible that fetal tissues other than
neural tissue may contribute to the AF concentration of
S100B.
The systemic inflammatory response syndrome (SIRS)
in critically ill patients may contribute to the elevated
serum S100B in adults. Tsao et al. proposed that SIRS
may affect the tone of systemic and cerebral vasculature,
increasing the permeability of the blood-brain barrier
facilitating diffusion of S100B w33x. Moreover, there is
experimental evidence that bacteria can increase the per-
meability of the blood-brain barrier, as demonstrated in
a mouse model of sepsis where disruption of brain
microvascular vessels was confirmed by transmission
electron microscopy. Indeed, intravenous injection of
tumor necrosis factor-a results in increased permeability
of the blood-brain barrier which is inhibited by anti-tumor
necrosis factor-a antibody w33x. Thus, increased fetal
plasma pro-inflammatory cytokines produced during the
fetal counterpart of SIRS, the fetal inflammatory response
syndrome w17x, may also lead to the disruption of the
fetal blood brain barrier permeability, facilitating release
of S100B from the fetal central nervous system without
concomitant neurological damage.
Strengths of the study
The strengths of the study include: (1) a large number of
patients per group (25–74); (2) consistent results of a
higher AF concentration of S100B with several parame-
ters of infection and inflammation in patients who deliv-
ered preterm following both preterm labor with intact
membranes or preterm PROM; and (3) multivariate logis-
tic regression analysis to determine whether AF concen-
tration of S100B was an independent explanatory
variable for neonatal morbidity or fetal/neonatal death.
Limitations/future research directions
Since the amnion is a possible source contributing to the
AF S100B concentration, the extent to which the amnion
produces S100B and whether or not its production is up-
regulated by microbial products should be explored. Pro-
spective studies are required to determine if a high AF
S100B concentration in the midtrimester or at the time
of the clinical presentation of preterm labor or preterm
PROM is associated with adverse long-term neurologic
outcome.
Conclusions
Patients who deliver preterm following preterm labor with
intact membranes or preterm PROM who have intra-
amniotic infection/inflammation have a higher AF con-
centration of S100B than those without intra-amniotic
infection/inflammation.
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